Another week of new all-time highs for the Dow Jones Industrial Average coupled with a good start to earnings season has given optimists little reason to fret. For skeptics like me, that's an opportunity to see whether companies have earned their current valuations.
Keep in mind that some companies�deserve�their current valuations. Life sciences company Life Technologies�jumped to new highs this week following word that Thermo Fisher Scientific�will make a bid for the company, and that other private-equity firms are finalizing their bids.�With Life Technologies having publicly announced a strategic review in January, it seems like a long-awaited buyout could be right around the corner for shareholders.
Still, other companies might deserve a kick in the pants. Here's a look at three companies that could be worth selling.
Leave the wrapper on
The returns on confectioner Tootsie Roll Industries (NYSE: TR ) have certainly been sweet for investors over the past year. You have to go back to the summer of 2010 to find sugar prices that were as low as they are now,�which has played a good part in helping Tootsie Roll keep that aspect of its costs down. But taking a bigger view of what's going on with Tootsie Roll and comparing that to its current valuation creates a sour taste in my mouth.
Hot Warren Buffett Companies To Buy For 2015: Navios Maritime Holdings Inc. (NM)
Navios Maritime Holdings Inc. operates as a seaborne shipping and logistics company. It focuses on the transportation and transshipment of dry bulk commodities, including iron ore, coal, fertilizers, and grains. The company controls a fleet of 31 owned vessels and 26 chartered-in vessels totaling 5.8 million dwt. Its owned fleet comprises 14 Ultra Handymax, 11 Capesize, 1 Handysize, and 3 Panamax vessels, as well as 2 Panamax vessels under construction; and chartered-in vessels consists of 8 Capesize, 11 Panamax, 1 Handysize, and 6 Ultra Handymax vessels under long-term time charters. The company also engages in port terminal, river barge, and coastal cabotage operations; and charters its vessels under medium to long-term charters to trading houses, producers, and government-owned entities. In addition, it engages in operating ports and transfer station terminals; and handles vessels, barges, and push boats, as well as operates upriver transport facilities in the Hidrovia region. Further, the company engages in the transportation and handling of liquid cargoes through the ownership, operation, and trading of tanker vessels. It has operations primarily in North America, Europe, Asia, and South America. The company is headquartered in Piraeus, Greece.
Advisors' Opinion:- [By Nickey Friedman]
Navios Maritime Holdings (NYSE: NM ) has two operating segments: shipping and logistics. Analysts have already begun to raise their profit estimates for 2014, currently at $0.11 EPS up from $0.01 a week ago. Expect that number to continue to rise dramatically. Navios pays a $0.06 per share quarterly dividend and trades around 40% below its book value. It used to trade as high as $17 back in 2007.
10 Best Life Sciences Stocks To Watch For 2014: Axis Capital Holdings Limited (AXS)
AXIS Capital Holdings Limited provides specialty lines insurance and treaty reinsurance products in Bermuda, the United States, Europe, Singapore, Canada, Australia, and Latin America. The company�s Insurance segment offers property insurance for commercial buildings, residential premises, construction projects, and onshore energy installations; marine insurance covering offshore energy, cargo, liability, recreational marine, fine art, specie, hull, and war; and aviation, terrorism, credit and political risk, and liability insurance. It also provides professional lines that cover directors� and officers� liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, and other financial insurance related coverage; and accidental death, travel, and specialty health products for employer and affinity groups, financial institutions, schools, and colleges, as well as accident and health reinsurance for catastrop hic or per life events. This segment offers its products through wholesale and retail brokers, managing general agents, and underwriters. Its Reinsurance segment provides non-life reinsurance to insurance companies, including catastrophe; property reinsurance covering property damage and related losses resulting from natural and man-made perils; professional lines; credit and bond reinsurance; and motor reinsurance providing coverage to cedants for motor liability and property damage losses. This segment also offers coverage to insurers of standard casualty business, excess and surplus casualty business, and specialty casualty programs; coverage for various types of construction risks and risks associated with the erection, testing, and commissioning of machinery and plants during the construction stage; and aviation, marine, personal accident, and crop reinsurance. AXIS Capital Holdings Limited was founded in 2001 and is headquartered in Pembroke, Bermuda.
Advisors' Opinion:- [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CINF is trading at a discount to only 3.) above. The stock is trading at a 36.8% premium to its calculated fair value of $34.96. CINF did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CINF earned two Stars in this section for 1.) and 2.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. The company has paid a cash dividend to shareholders every year since 1954 and has increased its dividend payments for 54 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $62 is below the $500 target I look for in a stock that has increased dividends as long as CINF has. If CINF grows its dividend at 1.2% per year, it will take 5 years to equal a MMA yielding an estimated 20-year average rate of 3.68%. Memberships and Peers: CINF is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Divid
10 Best Life Sciences Stocks To Watch For 2014: Solutia Inc(SOA)
Solutia Inc. and its subsidiaries manufacture performance materials and specialty chemicals used in various consumer and industrial applications. The company?s Advanced Interlayers segment provides polyvinyl butyral (PVB) sheet that is used in the manufacture of laminated glass for automotive and architectural applications, and as an encapsulant in photovoltaic applications primarily under the SAFLEX name; ethyl vinyl acetate films under the VISTASOLAR name for photovoltaic module encapsulation; and specialty intermediate PVB resin and plasticizer products under the BUTVAR name. Its Performance Films segment manufactures solar control, decorative, safety and security window films for aftermarket automotive and architectural applications under the LLUMAR, V-KOOL, H�ER OPTIK, VISTA, GILA, and FORMULA ONE HIGH PERFORMANCE AUTOMOTIVE TINT names; and advanced film components that are used in electronics and energy industrial products under the FLEXVUE name. The company?s Te chnical Specialties segment manufactures and sells chemicals for the rubber, solar energy, process manufacturing, and aviation industries. This segment offers insoluble sulfur under the CRYSTEX name; and antidegradants, which are used in pneumatic tire components, solid tires, belts, hoses, cables, automotive mounts, bushings, and general mechanical products under the SANTOFLEX name. This segment also provides heat transfer fluids that are used for indirect heating or cooling of chemical processes in various types of industrial equipment and in solar energy power systems under the THERMINOL name; and aviation hydraulic fluids for airline airframe manufacturers and aviation maintenance facilities under the SKYDROL name. The company sells its products to end users in various industries through distributors and franchisees, as well as through its sales force in the United States, Europe, the Asia Pacific, and internationally. Solutia Inc. was founded in 1901 and is headquartere d in St. Louis, Missouri.
Advisors' Opinion:- [By Holly LaFon]
His largest new buys in the first quarter are: Penn Virginia Group Holdings LP (PVG), Wynn Resorts Ltd. (WYNN), Methanex Corp. (MEOH), Solutia Inc. (SOA) and Georgia Gulf (GGC). Of his top eight stocks, five are from the chemicals industry.
10 Best Life Sciences Stocks To Watch For 2014: Affymetrix Inc.(AFFX)
Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets primarily in the United States, Europe, Japan. The company provides integrated GeneChip microarray platform, which includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. It also offers GeneTitan, an instrument system that runs genotyping and gene expression array plates; and GeneAtlas, an instrument for low-to-medium throughput that provides hybridization and array processing with microwell-based labware, as well as a line of multiplex assays to serve the discovery and the validation markets. In addition, the company provides reagent kits, including ExoSAP-IT fo r a reagent for the clean-up of polymerase chain reaction (PCR) products used in downstream applications, such as DNA sequencing or single-nucleotide polymorphisms analysis; and HotStart-IT reagents that utilize a novel primer binding protein to inhibit primer dimer formation with results in sensitive and consistent amplification for PCR. Its products are used primarily in genotyping and gene expression applications. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers, government research laboratories, private foundation laboratories, and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, the Middle East, and Asia Pacific regions. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.
Advisors' Opinion:- [By Bryan Murphy]
They say you're known by the caliber of company you keep. If that's true for stocks (and it is), then CollabRx Inc. (NASDAQ:CLRX) has a lot to be proud of with its new partnership with Affymetrix, Inc. (NASDAQ:AFFX). On the flipside, Affymetrix should be honored it's inked a deal with CollabRx. In a combination that hasn't been topped since peanut butter and chocolate hooked up to form a Reese's cup, AFFX and CLRX help bring out the best in each other.
- [By Monica Gerson]
Breaking news
Costco Wholesale (NASDAQ: COST) reported a 5% gain in its April same-store sales. Costco's US same-store sales climbed 5%, while international sales rose 2% in April. Analysts were estimating a 3.2% gain in April same store sales. To read the full news, click here. Dish Network (NASDAQ: DISH) reported an 18% drop in its first-quarter profit. Dish's quarterly earnings slipped to $175.9 million, or $0.38 per share, versus $215.6 million, or $0.47 per share, in the year-ago period. To read the full news, click here. Affymetrix (NASDAQ: AFFX) and Leica Biosystems announce the launch of Affymetrix' fully automated RNA in situ hybridization assays ViewRNATM eZ Assays on the Leica BOND RX staining platform. To read the full news, click here. Priceline Group (NASDAQ: PCLN) reported a 36% gain in its first-quarter earnings. Priceline's quarterly profit surged to $331.2 million, or $6.25 per share, versus a year-ago profit of $244.3 million, or $4.76 per share. To read the full news, click here.Posted-In: Morgan Stanley US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Rich Duprey]
It's in the genes
Elsewhere in the market, however,�Affymetrix (NASDAQ: AFFX ) tumbled more than 13% after preannouncing first-quarter earnings that missed even its own expectations. It blamed "headwinds" in its gene expression business everywhere it does business, though it suffered a particular shortfall in Japan. The Fool's Sean Williams thinks that may indicate more than a one-off performance issue because of the global nature of the miss Affymetrix suffered. - [By James E. Brumley]
Every year, more than 100,000 white papers on the topic of cancer and cancer treatments are published. Right now, there are over 500 new cancer drugs in development, and those therapies are part of more than 10,000 different clinical trials currently underway. That's all in addition to the already-approved cancer drugs, and the volumes of information we already know about oncology. What's it mean? It means the cancer-treating energy often suffers from information overload, which in turn means patients aren't getting the best care they could get. The solution is a tool built by a little company called CollabRx Inc. (NASDAQ:CLRX). The validation for that solution comes from much bigger companies Quest Diagnostics Inc. (NYSE:DGX) and Affymetrix, Inc. (NASDAQ:AFFX).
10 Best Life Sciences Stocks To Watch For 2014: Speedway Motorsports Inc.(TRK)
Speedway Motorsports, Inc., through its subsidiaries, operates as a promoter, marketer, and sponsor of motor sports activities in the United States. The company principally owns and operates Atlanta Motor Speedway, Bristol Motor Speedway, Charlotte Motor Speedway, Infineon Raceway, Kentucky Speedway, Las Vegas Motor Speedway, New Hampshire Motor Speedway, and Texas Motor Speedway racing facilities. The company also provides souvenir merchandising services; food, beverage, and hospitality catering services; and radio programming, production, and distribution services. In addition, it develops electronic media promotional programming; and distributes wholesale and retail racing, and other sports related souvenir merchandise and apparel. Further, the company manufactures and distributes smaller-scale, modified racing cars and parts; and produces and sells an environmentally-friendly micro-lubricant. Speedway Motorsports has a joint venture with International Speedway Corporat ion to produce, market, and sell licensed motorsports collectible and consumer products, primarily trackside event souvenir merchandising. The company was founded in 1959 and is based in Concord, North Carolina.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Speedway Motorsports (NYSE: TRK ) , whose recent revenue and earnings are plotted below. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Speedway Motorsports (NYSE: TRK ) , whose recent revenue and earnings are plotted below. - [By Patricio Kehoe]
The motorsports industry is a natural monopoly at the local level, since only one racetrack can hold NASCAR events in each market, and until now, International Speedway has won this battle. Nevertheless, over the past five years, this company has suffered under declining ticket and concession spending, due to a weak demographic fan base located in troubled geographies. Although recent racetrack changes and customer stabilization will leave ISCA well positioned when spending power increases once again, this is bound to happen at a slow pace. However, the distinct properties of each racetrack attract high brand loyalty, and have compelled competitors like Speedway Motorsports Inc. (TRK) to focus business on completely different markets, therefore posing no real threat to ISCA.
10 Best Life Sciences Stocks To Watch For 2014: Tsakos Energy Navigation Ltd(TNP)
Tsakos Energy Navigation Limited, together with its subsidiaries, provides seaborne crude oil and petroleum product transportation services worldwide. The company offers marine transportation services for national and independent oil companies and refiners under long, medium, and short-term charters. As of August 16, 2011, its fleet consisted of 50 vessels comprising 59 tankers, including 2 dynamic positioning 2 (DP2) shuttle tankers under construction, and 1 liquefied natural gas carrier. The company was formerly known as MIF Limited and changed its name to Tsakos Energy Navigation Limited in July 2001. Tsakos Energy Navigation Limited was founded in 1993 and is based in Athens, Greece.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of energy transporter Tsakos Energy Navigation Limited (NYSE: TNP ) jumped 17% today after the company released earnings.
- [By Rick Munarriz]
We can start with Tsakos Energy Navigation Limited (NYSE: TNP ) . Shares of the energy transporter moved 27% higher last week after surprising the market with a quarterly profit. Business isn't great at Tsakos. Revenue dipped slightly during the period, and a profit of $0.02 a share may not turn heads. However, analysts were bracing for a loss of $0.08 a share on a sharper decline in revenue.
10 Best Life Sciences Stocks To Watch For 2014: Ishares Msci Australia Inc (EWA)
iShares MSCI Australia Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Australian market, as measured by the MSCI Australia Index (the Index). The Index seeks to measure the performance of the Australian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Chad Fraser]
Another option is to buy units of an Australian exchange traded fund (ETF) like the iShares MSCI Australia Index Fund (NYSE: EWA), one of the investments we cover in Australian Edge’s How They Rate universe, which keeps over 100 Australian companies and other investments under continuous review.
No comments:
Post a Comment